Diabetes, Vol 48, Issue 9 1698-1705, Copyright © 1999 by American Diabetes Association

ARTICLES

Structural model of human glucokinase in complex with glucose and ATP: implications for the mutants that cause hypo- and hyperglycemia

B Mahalingam, A Cuesta-Munoz, EA Davis, FM Matschinsky, RW Harrison and IT Weber
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

Mutations in human glucokinase are implicated in the development of diabetes and hypoglycemia. Human glucokinase shares 54% identical amino acid residues with human brain hexokinase I. This similarity was used to model the structure of glucokinase by analogy to the crystal structure of brain hexokinase. Glucokinase was modeled with both its substrates, glucose and MgATP, to understand the effect of mutations. The glucose is predicted to form hydrogen bond interactions with the side chains of glucokinase residues Thr 168, Lys 169, Asn 204, Asp 205, Asn 231, and Glu 290, similar to those observed for brain hexokinase I. The magnesium ion is coordinated by the carboxylates of Asp 78 and Asp 205 and the gamma-phosphate of ATP. ATP is predicted to form hydrogen bond interactions with residues Gly 81, Thr 82, Asn 83, Arg 85, Lys 169, Thr 228, Lys 296, Thr 332, and Ser 336. Mutations of residues close to the predicted ATP binding site produced dramatic changes in the Km for ATP, the catalytic rate, and a loss of cooperativity, which confirmed our model. Mutations of residues in the glucose binding site dramatically reduced the catalytic activity, as did a mutation that was predicted to disrupt an alpha-helix. Other mutations located far from the active site gave smaller changes in kinetic parameters. In the absence of a crystal structure for glucokinase, our models help rationalize the potential effects of mutations in diabetes and hypoglycemia, and the models may also facilitate the discovery of pharmacological glucokinase activators and inhibitors.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Berradi, M. D. Bernadet, G. Guy, and N. Rideau Expression of the Glucokinase Gene in Mule Duck Liver and Glucokinase Activities in Chicken and Mule Duck Livers Poult. Sci., October 1, 2007; 86(10): 2216 - 2220. [Abstract] [Full Text] [PDF]

				S. Baltrusch and M. Tiedge Glucokinase Regulatory Network in Pancreatic {beta}-Cells and Liver Diabetes, December 1, 2006; 55(Supplement_2): S55 - S64. [Abstract] [Full Text] [PDF]

				J. V. Sagen, S. Odili, L. Bjorkhaug, D. Zelent, C. Buettger, J. Kwagh, C. Stanley, K. Dahl-Jorgensen, C. de Beaufort, G. I. Bell, et al. From Clinicogenetic Studies of Maturity-Onset Diabetes of the Young to Unraveling Complex Mechanisms of Glucokinase Regulation Diabetes, June 1, 2006; 55(6): 1713 - 1722. [Abstract] [Full Text] [PDF]

				F. M. Matschinsky, M. A. Magnuson, D. Zelent, T. L. Jetton, N. Doliba, Y. Han, R. Taub, and J. Grimsby The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy Diabetes, January 1, 2006; 55(1): 1 - 12. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, S. Odili, D. Zelent, C. Buettger, H. A. J. Castleden, A. M. Steele, A. Stride, C. Shiota, M. A. Magnuson, R. Lorini, et al. Insights into the Structure and Regulation of Glucokinase from a Novel Mutation (V62M), Which Causes Maturity-onset Diabetes of the Young J. Biol. Chem., April 8, 2005; 280(14): 14105 - 14113. [Abstract] [Full Text] [PDF]

				A. L. Cuesta-Munoz, H. Huopio, T. Otonkoski, J. M. Gomez-Zumaquero, K. Nanto-Salonen, J. Rahier, S. Lopez-Enriquez, M. A. Garcia-Gimeno, P. Sanz, F. C. Soriguer, et al. Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation Diabetes, August 1, 2004; 53(8): 2164 - 2168. [Abstract] [Full Text] [PDF]

				P. R. Njolstad, J. V. Sagen, L. Bjorkhaug, S. Odili, N. Shehadeh, D. Bakry, S. U. Sarici, F. Alpay, J. Molnes, A. Molven, et al. Permanent Neonatal Diabetes Caused by Glucokinase Deficiency: Inborn Error of the Glucose-Insulin Signaling Pathway Diabetes, November 1, 2003; 52(11): 2854 - 2860. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, K. Noordam, M. A.A.P. Willemsen, S. Ellard, W. W.K. Lam, I. W. Campbell, P. Midgley, C. Shiota, C. Buettger, M. A. Magnuson, et al. Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations Diabetes, September 1, 2003; 52(9): 2433 - 2440. [Abstract] [Full Text] [PDF]

				F. M. Matschinsky Regulation of Pancreatic {beta}-Cell Glucokinase: From Basics to Therapeutics Diabetes, December 1, 2002; 51(90003): S394 - 404. [Abstract] [Full Text] [PDF]

				R. Barrio, C. Bellanne-Chantelot, J. C. Moreno, V. Morel, H. Calle, M. Alonso, and C. Mustieles Nine Novel Mutations in Maturity-Onset Diabetes of the Young (MODY) Candidate Genes in 22 Spanish Families J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2532 - 2539. [Abstract] [Full Text] [PDF]

				H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al. The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy Diabetes, April 1, 2002; 51(4): 1240 - 1246. [Abstract] [Full Text] [PDF]

				P. R. Njolstad, O. Sovik, A. Cuesta-Munoz, L. Bjorkhaug, O. Massa, F. Barbetti, D. E. Undlien, C. Shiota, M. A. Magnuson, A. Molven, et al. Neonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency N. Engl. J. Med., May 24, 2001; 344(21): 1588 - 1592. [Full Text] [PDF]